Skating on thin ice: Stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis

J. Carlo Hojilla, David Vlahov, David V. Glidden, K. Rivet Amico, Megha Mehrotra, Robert Hance, Robert M. Grant, Adam W. Carrico

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Stimulant and heavy alcohol use are prevalent and associated with elevated risk for HIV seroconversion among men who have sex with men (MSM) and transgender women. In addition, each can pose difficulties for antiretroviral adherence among people living with HIV. Scant research has examined the associations of stimulant and heavy alcohol use with adherence to daily oral pre-exposure prophylaxis (PrEP) among MSM and transgender women. To address this gap in the literature, we evaluated the hypothesis that stimulant use and binge drinking are prospectively associated with sub-optimal PrEP adherence. Methods: We analysed data from participants in a nested case-cohort in the iPrEx open label extension. Stimulant use (i.e. powder cocaine, crack-cocaine, cocaine paste, methamphetamine, cathinone) and binge drinking (i.e. ≥5 drinks in a single day) in the last 30 days were assessed. Baseline urine was tested for stimulants using immunoassays to reduce misclassification. Sub-optimal adherence was defined as tenofovir drug concentrations in dried blood spots less than 700 fmol per punch, indicative of less than four doses per week. We tested the prospective association of stimulant use and binge drinking with sub-optimal adherence at the 4-week follow-up visit. Results and Discussion: Data from 330 participants were analysed. The majority of the participants were MSM (89%) with a median age at baseline of 29 years (interquartile range 24 to 39). Approximately 16% (52/330) used stimulants and 22% (72/ 330) reported binge drinking in the last 30 days. Stimulant users had fivefold greater odds of sub-optimal PrEP adherence compared to non-users in adjusted analysis (adjusted odds ratio [aOR] 5.04; [95% CI 1.35 to 18.78]). Self-reported binge drinking was not significantly associated with sub-optimal adherence after adjusting for stimulant use and baseline confounders (aOR 1.16 [0.49 to 2.73]). Depressive symptoms, being transgender, and number of sex partners were also not significantly associated with sub-optimal PrEP adherence (p > 0.05). Conclusions: Stimulant use is a risk factor for sub-optimal PrEP adherence in the month following PrEP initiation. Comprehensive prevention approaches that reduce stimulant use may optimize PrEP adherence. Creating adherence plans that specifically address PrEP dosing in the context of ongoing stimulant use should also be considered.

Original languageEnglish (US)
Article numbere25103
JournalJournal of the International AIDS Society
Volume21
Issue number3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Binge Drinking
HIV
Transgender Persons
Tenofovir
Cocaine
Odds Ratio
Alcohols
Crack Cocaine
HIV Seropositivity
Methamphetamine
Pre-Exposure Prophylaxis
Ointments
Immunoassay
Powders
Urine
Depression
Research
Pharmaceutical Preparations

Keywords

  • Adherence
  • Binge drinking
  • Drug use
  • Men who have sex with men
  • Pre-exposure prophylaxis
  • Stimulant use
  • Transgender persons

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Skating on thin ice : Stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis. / Hojilla, J. Carlo; Vlahov, David; Glidden, David V.; Amico, K. Rivet; Mehrotra, Megha; Hance, Robert; Grant, Robert M.; Carrico, Adam W.

In: Journal of the International AIDS Society, Vol. 21, No. 3, e25103, 01.01.2018.

Research output: Contribution to journalArticle

Hojilla, J. Carlo ; Vlahov, David ; Glidden, David V. ; Amico, K. Rivet ; Mehrotra, Megha ; Hance, Robert ; Grant, Robert M. ; Carrico, Adam W. / Skating on thin ice : Stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis. In: Journal of the International AIDS Society. 2018 ; Vol. 21, No. 3.
@article{ae94041342f047feb60ddacb76405bf2,
title = "Skating on thin ice: Stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis",
abstract = "Stimulant and heavy alcohol use are prevalent and associated with elevated risk for HIV seroconversion among men who have sex with men (MSM) and transgender women. In addition, each can pose difficulties for antiretroviral adherence among people living with HIV. Scant research has examined the associations of stimulant and heavy alcohol use with adherence to daily oral pre-exposure prophylaxis (PrEP) among MSM and transgender women. To address this gap in the literature, we evaluated the hypothesis that stimulant use and binge drinking are prospectively associated with sub-optimal PrEP adherence. Methods: We analysed data from participants in a nested case-cohort in the iPrEx open label extension. Stimulant use (i.e. powder cocaine, crack-cocaine, cocaine paste, methamphetamine, cathinone) and binge drinking (i.e. ≥5 drinks in a single day) in the last 30 days were assessed. Baseline urine was tested for stimulants using immunoassays to reduce misclassification. Sub-optimal adherence was defined as tenofovir drug concentrations in dried blood spots less than 700 fmol per punch, indicative of less than four doses per week. We tested the prospective association of stimulant use and binge drinking with sub-optimal adherence at the 4-week follow-up visit. Results and Discussion: Data from 330 participants were analysed. The majority of the participants were MSM (89{\%}) with a median age at baseline of 29 years (interquartile range 24 to 39). Approximately 16{\%} (52/330) used stimulants and 22{\%} (72/ 330) reported binge drinking in the last 30 days. Stimulant users had fivefold greater odds of sub-optimal PrEP adherence compared to non-users in adjusted analysis (adjusted odds ratio [aOR] 5.04; [95{\%} CI 1.35 to 18.78]). Self-reported binge drinking was not significantly associated with sub-optimal adherence after adjusting for stimulant use and baseline confounders (aOR 1.16 [0.49 to 2.73]). Depressive symptoms, being transgender, and number of sex partners were also not significantly associated with sub-optimal PrEP adherence (p > 0.05). Conclusions: Stimulant use is a risk factor for sub-optimal PrEP adherence in the month following PrEP initiation. Comprehensive prevention approaches that reduce stimulant use may optimize PrEP adherence. Creating adherence plans that specifically address PrEP dosing in the context of ongoing stimulant use should also be considered.",
keywords = "Adherence, Binge drinking, Drug use, Men who have sex with men, Pre-exposure prophylaxis, Stimulant use, Transgender persons",
author = "Hojilla, {J. Carlo} and David Vlahov and Glidden, {David V.} and Amico, {K. Rivet} and Megha Mehrotra and Robert Hance and Grant, {Robert M.} and Carrico, {Adam W.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jia2.25103",
language = "English (US)",
volume = "21",
journal = "Journal of the International AIDS Society",
issn = "1758-2652",
publisher = "International AIDS Society",
number = "3",

}

TY - JOUR

T1 - Skating on thin ice

T2 - Stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis

AU - Hojilla, J. Carlo

AU - Vlahov, David

AU - Glidden, David V.

AU - Amico, K. Rivet

AU - Mehrotra, Megha

AU - Hance, Robert

AU - Grant, Robert M.

AU - Carrico, Adam W.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Stimulant and heavy alcohol use are prevalent and associated with elevated risk for HIV seroconversion among men who have sex with men (MSM) and transgender women. In addition, each can pose difficulties for antiretroviral adherence among people living with HIV. Scant research has examined the associations of stimulant and heavy alcohol use with adherence to daily oral pre-exposure prophylaxis (PrEP) among MSM and transgender women. To address this gap in the literature, we evaluated the hypothesis that stimulant use and binge drinking are prospectively associated with sub-optimal PrEP adherence. Methods: We analysed data from participants in a nested case-cohort in the iPrEx open label extension. Stimulant use (i.e. powder cocaine, crack-cocaine, cocaine paste, methamphetamine, cathinone) and binge drinking (i.e. ≥5 drinks in a single day) in the last 30 days were assessed. Baseline urine was tested for stimulants using immunoassays to reduce misclassification. Sub-optimal adherence was defined as tenofovir drug concentrations in dried blood spots less than 700 fmol per punch, indicative of less than four doses per week. We tested the prospective association of stimulant use and binge drinking with sub-optimal adherence at the 4-week follow-up visit. Results and Discussion: Data from 330 participants were analysed. The majority of the participants were MSM (89%) with a median age at baseline of 29 years (interquartile range 24 to 39). Approximately 16% (52/330) used stimulants and 22% (72/ 330) reported binge drinking in the last 30 days. Stimulant users had fivefold greater odds of sub-optimal PrEP adherence compared to non-users in adjusted analysis (adjusted odds ratio [aOR] 5.04; [95% CI 1.35 to 18.78]). Self-reported binge drinking was not significantly associated with sub-optimal adherence after adjusting for stimulant use and baseline confounders (aOR 1.16 [0.49 to 2.73]). Depressive symptoms, being transgender, and number of sex partners were also not significantly associated with sub-optimal PrEP adherence (p > 0.05). Conclusions: Stimulant use is a risk factor for sub-optimal PrEP adherence in the month following PrEP initiation. Comprehensive prevention approaches that reduce stimulant use may optimize PrEP adherence. Creating adherence plans that specifically address PrEP dosing in the context of ongoing stimulant use should also be considered.

AB - Stimulant and heavy alcohol use are prevalent and associated with elevated risk for HIV seroconversion among men who have sex with men (MSM) and transgender women. In addition, each can pose difficulties for antiretroviral adherence among people living with HIV. Scant research has examined the associations of stimulant and heavy alcohol use with adherence to daily oral pre-exposure prophylaxis (PrEP) among MSM and transgender women. To address this gap in the literature, we evaluated the hypothesis that stimulant use and binge drinking are prospectively associated with sub-optimal PrEP adherence. Methods: We analysed data from participants in a nested case-cohort in the iPrEx open label extension. Stimulant use (i.e. powder cocaine, crack-cocaine, cocaine paste, methamphetamine, cathinone) and binge drinking (i.e. ≥5 drinks in a single day) in the last 30 days were assessed. Baseline urine was tested for stimulants using immunoassays to reduce misclassification. Sub-optimal adherence was defined as tenofovir drug concentrations in dried blood spots less than 700 fmol per punch, indicative of less than four doses per week. We tested the prospective association of stimulant use and binge drinking with sub-optimal adherence at the 4-week follow-up visit. Results and Discussion: Data from 330 participants were analysed. The majority of the participants were MSM (89%) with a median age at baseline of 29 years (interquartile range 24 to 39). Approximately 16% (52/330) used stimulants and 22% (72/ 330) reported binge drinking in the last 30 days. Stimulant users had fivefold greater odds of sub-optimal PrEP adherence compared to non-users in adjusted analysis (adjusted odds ratio [aOR] 5.04; [95% CI 1.35 to 18.78]). Self-reported binge drinking was not significantly associated with sub-optimal adherence after adjusting for stimulant use and baseline confounders (aOR 1.16 [0.49 to 2.73]). Depressive symptoms, being transgender, and number of sex partners were also not significantly associated with sub-optimal PrEP adherence (p > 0.05). Conclusions: Stimulant use is a risk factor for sub-optimal PrEP adherence in the month following PrEP initiation. Comprehensive prevention approaches that reduce stimulant use may optimize PrEP adherence. Creating adherence plans that specifically address PrEP dosing in the context of ongoing stimulant use should also be considered.

KW - Adherence

KW - Binge drinking

KW - Drug use

KW - Men who have sex with men

KW - Pre-exposure prophylaxis

KW - Stimulant use

KW - Transgender persons

UR - http://www.scopus.com/inward/record.url?scp=85055257076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055257076&partnerID=8YFLogxK

U2 - 10.1002/jia2.25103

DO - 10.1002/jia2.25103

M3 - Article

C2 - 29577616

AN - SCOPUS:85055257076

VL - 21

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

SN - 1758-2652

IS - 3

M1 - e25103

ER -